Literature DB >> 28652253

SPIN90 Depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression.

Eunae You1, Yun Hyun Huh2, Ahreum Kwon2, So Hee Kim2, In Hee Chae2, Ok-Jun Lee3, Je-Hwang Ryu4, Min Ho Park5, Ga-Eon Kim6, Ji Shin Lee6, Kun Ho Lee7, Yong-Seok Lee1, Jung-Woong Kim1, Sangmyung Rhee8, Woo Keun Song9.   

Abstract

Biomechanical remodeling of stroma by cancer-associated fibroblasts (CAF) in early stages of cancer is critical for cancer progression, and mechanical cues such as extracellular matrix stiffness control cell differentiation and malignant progression. However, the mechanism by which CAF activation occurs in low stiffness stroma in early stages of cancer is unclear. Here, we investigated the molecular mechanism underlying CAF regulation by SPIN90 and microtubule acetylation under conditions of mechanically soft matrices corresponding to normal stromal rigidity. SPIN90 was downregulated in breast cancer stroma but not tumor, and this low stromal expression correlated with decreased survival in breast cancer patients. Spin90 deficiency facilitated recruitment of mDia2 and APC complex to microtubules, resulting in increased microtubule acetylation. This increased acetylation promoted nuclear localization of YAP, which upregulated expression of myofibroblast marker genes on soft matrices. Spin90 depletion enhanced tumor progression, and blockade of microtubule acetylation in CAF significantly inhibited tumor growth in mice. Together, our data demonstrate that loss of SPIN90-mediated microtubule acetylation is a key step in CAF activation in low stiffness stroma. Moreover, correlation among these factors in human breast cancer tissue supports the clinical relevance of SPIN90 and microtubule acetylation in tumor development. Cancer Res; 77(17); 4710-22. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28652253     DOI: 10.1158/0008-5472.CAN-17-0657

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Cell mediated remodeling of stiffness matched collagen and fibrin scaffolds.

Authors:  Alicja Jagiełło; Ulysses Castillo; Elliot Botvinick
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

Review 2.  Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors.

Authors:  Seiichiro Ishihara; Hisashi Haga
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

Review 3.  Mechanical Cues Regulate Histone Modifications and Cell Behavior.

Authors:  Buwei Hu; Dandan Zhou; Haoming Wang; Ning Hu; Weikang Zhao
Journal:  Stem Cells Int       Date:  2022-05-11       Impact factor: 5.131

4.  Global DNA Methylation Profiles in Peripheral Blood of WTC-Exposed Community Members with Breast Cancer.

Authors:  Stephanie Tuminello; Yian Zhang; Lei Yang; Nedim Durmus; Matija Snuderl; Adriana Heguy; Anne Zeleniuch-Jacquotte; Yu Chen; Yongzhao Shao; Joan Reibman; Alan A Arslan
Journal:  Int J Environ Res Public Health       Date:  2022-04-22       Impact factor: 4.614

Review 5.  A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Authors:  Masahiro Shibata; Kendall Ham; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-07-24       Impact factor: 7.396

6.  Establishment of a 12-gene expression signature to predict colon cancer prognosis.

Authors:  Dalong Sun; Jing Chen; Longzi Liu; Guangxi Zhao; Pingping Dong; Bingrui Wu; Jun Wang; Ling Dong
Journal:  PeerJ       Date:  2018-06-14       Impact factor: 2.984

7.  Tumor-derived miR-130b-3p induces cancer-associated fibroblast activation by targeting SPIN90 in luminal A breast cancer.

Authors:  Suyeon Ahn; Ahreum Kwon; Yun Hyun Huh; Sangmyung Rhee; Woo Keun Song
Journal:  Oncogenesis       Date:  2022-08-10       Impact factor: 6.524

8.  Casein kinase 2 promotes the TGF-β-induced activation of α-tubulin acetyltransferase 1 in fibroblasts cultured on a soft matrix.

Authors:  Eunae You; Jangho Jeong; Jieun Lee; Seula Keum; Ye Eun Hwang; Jee-Hye Choi; Sangmyung Rhee
Journal:  BMB Rep       Date:  2022-04       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.